<DOC>
	<DOCNO>NCT01654640</DOCNO>
	<brief_summary>The purpose study evaluation effect metformin obesity metabolic disturbance patient take clozapine .</brief_summary>
	<brief_title>The Effect Metformin Obesity Metabolic Disturbance Patients Taking Clozapine</brief_title>
	<detailed_description>In study , investigator go examine effect metformin obesity metabolic disturbance patient schizophrenia take clozapine.The metformin 500mg administrate per oral twice day 24 week control group , placebo give route process .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Age : 18 ~ 65 Patient schizophrenia accord DSMIV criterion Patient sign informed consent , well understood objective procedure study . Patient take clozapine 3months Patient increase weight 10 % antipsychotic use Patient take antipsychotic clozapine Patient treatment diabetes Patient treatment dyslipidemia Allergy hypersensitivity metformin Pregnant breastfeed female patient . Patient severe medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>obesity</keyword>
	<keyword>clozapine</keyword>
	<keyword>metformin</keyword>
</DOC>